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N-WASP is required for Amphiphysin-2/BIN1-
dependent nuclear positioning and triad
organization in skeletal muscle and is involved in
the pathophysiology of centronuclear myopathy
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Abstract
Mutations in amphiphysin-2/BIN1, dynamin 2, and myotubularin
are associated with centronuclear myopathy (CNM), a muscle
disorder characterized by myofibers with atypical central nuclear
positioning and abnormal triads. Mis-splicing of amphiphysin-2/
BIN1 is also associated with myotonic dystrophy that shares
histopathological hallmarks with CNM. How amphiphysin-2
orchestrates nuclear positioning and triad organization and how
CNM-associated mutations lead to muscle dysfunction remains elusive.
We find that N-WASP interacts with amphiphysin-2 in myofibers
and that this interaction and N-WASP distribution are disrupted by
amphiphysin-2 CNM mutations. We establish that N-WASP func-
tions downstream of amphiphysin-2 to drive peripheral nuclear
positioning and triad organization during myofiber formation.
Peripheral nuclear positioning requires microtubule/Map7/Kif5b-
dependent distribution of nuclei along the myofiber and is driven
by actin and nesprins. In adult myofibers, N-WASP and amphiphy-
sin-2 are only involved in the maintenance of triad organization
but not in the maintenance of peripheral nuclear positioning.
Importantly, we confirmed that N-WASP distribution is disrupted
in CNM and myotonic dystrophy patients. Our results support a
role for N-WASP in amphiphysin-2-dependent nuclear positioning
and triad organization and in CNM and myotonic dystrophy patho-
physiology.
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Introduction
Centronuclear myopathy (CNM) is a rare neuromuscular disease
associated with skeletal muscle weakness and hypotonia (Pierson
et al, 2005; Nicot et al, 2007). CNM muscle fibers from patients
and mouse models have centrally positioned nuclei and exhibit
defects in T-tubules, triads, and excitation–contraction coupling
(Al-Qusairi et al, 2009; Dowling et al, 2009; Toussaint et al,
2011). Unlike many myopathies, centrally positioned nuclei in
CNMs are not linked to excessive degeneration–regeneration
processes. Several forms of CNM have been described in humans
including the X-linked form (XLCNM, OMIM#310400), which
exhibits the most severe phenotype and affects newborns, due to
mutations in myotubularin (MTM1), a phosphoinositide phospha-
tase (Laporte et al, 1996), the autosomal dominant form (AD-
CNM, OMIM#160150) due to mutations in dynamin 2 (DNM2), a
large GTPase (Bitoun et al, 2005), and an autosomal recessive
form (ARCNM, OMIM#255200) due to mutations in AMPH2/BIN1
(Nicot et al, 2007).
During skeletal muscle development, nuclei move toward the
center of the myotube after myoblast fusion and spread along
the center of the myotube prior to positioning at the periphery of the
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myofiber (Cadot et al, 2012; Metzger et al, 2012). Nuclear spreading
along the myotube is mediated by microtubules, Map7, and Kif5b
microtubule-binding proteins and is independent of nesprin proteins
(Metzger et al, 2012). Nesprins are nuclear envelope proteins that
tether the nucleus to the actin cytoskeleton (Zhang et al, 2007).
Myofibers lacking nesprins exhibit peripheral nuclear positioning
defects, but it is unknown at which stage of skeletal muscle develop-
ment nesprins are involved in nuclear positioning. Furthermore,
how CNM mutated genes are involved in nuclear positioning is also
unknown.
Amphiphysin-2 (amph2), encoded by AMPH2/BIN1, is involved
in T-tubule biogenesis and a skeletal muscle-specific isoform of
amph2 expressing exon 11 is localized to the T-tubules (Butler et al,
1997; Lee et al, 2002; Toussaint et al, 2011). T-tubules are invagin-
ations of the plasma membrane (sarcolemma) that become associ-
ated and transversally paired with a specific region of the
sarcoplasmic reticulum (SR), the junctional SR/terminal cisternae.
The structure formed between one T-tubule and two junctional SR
compartments is named triad (Flucher et al, 1991). Triads couple
the excitation of the sarcolemma and T-tubules with the release of
calcium from the SR leading to muscle contraction, a process named
excitation–contraction (EC) coupling. Multiple proteins are specifi-
cally localized in these structures, but the molecular mechanisms
involved in triad organization are still poorly understood (Al-Qusairi
& Laporte, 2011).
Alternative splicing of amph2 has been recently found in skeletal
muscle biopsies from patients with myotonic dystrophy. CNM and
myotonic dystrophy share some histopathological features such as
centrally positioned nuclei and defects in T-tubules and triads
(Fugier et al, 2011), suggesting a common unknown mechanism
involving a role for amph2 on nuclear positioning and triad function
in both CNM and myotonic dystrophy.
Amph2 has an N-terminal BAR domain responsible for membrane
binding and curvature, and a C-terminal SH3 domain implicated in
protein–protein interaction. These domains are mutated in ARCNM
patients (Nicot et al, 2007; Prokic et al, 2014). SH3 domains interact
and regulate multiple protein machineries, in particular different
actin nucleation promoting factors involved in membrane remodel-
ing (Suetsugu & Gautreau, 2012). N-WASP is an actin nucleation
promoting factor that activates the Arp2/3 complex, an actin nuclea-
tor (Rohatgi et al, 1999). In skeletal muscle, N-WASP was recently
found to be involved in myoblast fusion, nebulin-dependent actin
nucleation during myofibrillogenesis, and IGF-1-dependent muscle
hypertrophy (Takano et al, 2010; Gruenbaum-Cohen et al, 2012).
However, a role for N-WASP in nuclear positioning and triad organi-
zation is unknown. Amphiphysin-1, a member of the amphiphysin
family expressed primarily in the brain, regulates actin dynamics
and membrane remodeling during endocytosis through activation of
N-WASP (Yamada et al, 2009). Furthermore, a cardiac muscle-
specific amph2 isoform interacts with N-WASP in vitro (Hong et al,
2014). We therefore explored the potential involvement of N-WASP
downstream of amph2, a homolog of amphiphysin-1, in nuclear
positioning and triad organization during skeletal myofiber matura-
tion and its role in the pathophysiology of centronuclear myopathy
and myotonic dystrophy.
Results
In vitro maturation of myofibers with peripheral nuclei and
organized triads
During myofiber maturation, a complex network of signaling and
cytoskeletal proteins operate to organize cellular structures such
as contractile myofibrils and triads that allow EC coupling. In
parallel, nuclei move from the center of the myofiber to the
periphery (Franzini-Armstrong, 1986; Flucher et al, 1991; Starr &
Fridolfsson, 2010; Metzger et al, 2012). Multiple myogenic cell
lines along with primary myoblasts will readily differentiate into
myotubes in culture (Blau et al, 1985; Davis et al, 1987). Thus far,
it has proven difficult to generate mature myofibers in vitro with
T-tubules transversally paired with SR in striated transversal triads
and peripheral nuclei (Flucher et al, 1991; Cooper et al, 2004;
Cusimano et al, 2009). We therefore developed an in vitro system
in which we used primary myoblasts isolated from WT or histone
2B-GFP (H2B-GFP) P5 mouse pups to generate mature myofibers
(Hadjantonakis & Papaioannou, 2004). The H2B-GFP allowed us
to visualize nuclei positioning by time-lapse microscopy (Fig 1A).
Primary myoblasts were differentiated into myotubes and treated
with agrin. Myotubes were then covered with a matrigel layer, as
described in the Materials and Methods section and Supplementary
Fig S1A. We observed the maturation of these myotubes treated
with agrin by dual color phase-contrast/epi-fluorescence multi-
positioning time-lapse microscopy over a period of 10 days
Figure 1. Peripheral localization of nuclei and organization of transversal T-tubules paired with sarcoplasmic reticulum (SR) in in vitro myofibers.
A Images from a representative time-lapse dual color phase-contrast movie of H2B-GFP myotubes (Supplementary Movie S1), recorded from day 1 (after agrin addition)
until day 10, showing nuclear positioning to the periphery during myofiber maturation. Arrowhead indicates an example of a nucleus going to the periphery. Bar,
15 µm.
B Quantification of peripheral nuclei in H2B-GFP and WT myofibers, treated or untreated with agrin and differentiated for 5 or 10 days. Error bars, s.e.m., n = 3. P-values
from t-test (untreated versus treated condition).
C Representative immunofluorescence images of WT myofibers treated with agrin for 5 days immunostained for DHPR (red), a T-tubule marker, triadin (green), a
junctional SR marker, and DAPI (blue). On the right are 2× magnifications of rectangles. Bar, 15 lm.
D Representative immunofluorescence images of WT myofibers treated with agrin for 10 days immunostained for DHPR (red), triadin (green), and DAPI (blue). On the
right are 2× magnifications of rectangles. Bar, 15 lm.
E Quantification of transversal triads in WT myofibers treated or untreated with agrin and differentiated for 5 or 10 days. Error bars, s.e.m., n = 3. P-values from t-test
(untreated versus treated condition).
F Representative electron microscopy image of WT primary myofibers, transfected with GAPDH siRNA and treated with agrin for 10 days. Bar 1 µm.
G Magnification of the rectangle in (F). Arrows indicate triads located between myofibrils at the level of A–I border. Bar 500 nm. Inset: high magnification of the right
lower triad. Arrowheads indicate the RyR feet. Bar 100 nm. SR: sarcoplasmic reticulum.
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(Fig 1A, Supplementary Movie S1). Myotubes elongated and their
nuclei migrated and rotated throughout the length of the myotube
during differentiation. Nuclear movements decreased during differ-
entiation, and nuclei became positioned at the periphery of the
myofiber between day 5 and day 10 (Fig 1A). We also observed
migration of mononucleated cells, sometimes touching the myofi-
bers, although we never observed fusion between mononucleated
cells and differentiating myofibers after agrin addition. After
10 days, we noted increased myofiber detachment and death.
To quantify the percentage of peripheral nuclei observed during
myofiber maturation, cell cultures from WT and H2B-GFP mice
were fixed 5 and 10 days after agrin addition and immunostained
for dihydropyridine receptor (DHPR) and triadin. DHPR, a voltage-
gated channel, is found at the T-tubules. Triadin, an adaptor
protein, is found at the junctional SR compartment (Flucher et al,
1991; Marty et al, 2000). DHPR and triadin are not expressed in
mononucleated myoblasts (Marty et al, 2000; Zheng et al, 2002)
which allowed us to distinguish between peripheral nuclei in
myofibers from nuclei in mononucleated cells attached to the
myofibers (Supplementary Fig S1B). Five days after agrin addition,
about 20% of nuclei were observed at the periphery in either WT
or H2B-GFP myofibers (Fig 1B). DHPR and triadin were found
throughout the cytoplasm in clusters (Fig 1C). Ten days after the
addition of agrin, 70% of nuclei were positioned at the periphery
of the myofiber (Fig 1B and D). Remarkably, we observed that
DHPR and triadin were organized in a striated pattern of triads
(Fig 1D). Hence, the percentage of fibers with organized triads
was also measured 5 and 10 days after agrin addition. We scored
20% of myofibers with organized triads 5 days after agrin addition
and up to 80% of myofibers with transversal triads 10 days after
agrin addition (Fig 1E). Electron microscopy (EM) confirmed the
organization of triads transversally with one T-tubule coupled with
two terminal cisternae of the SR and ryanodine receptor (RyR) feet
(Fig 1F and G). Finally, we analyzed myofibrillogenesis during
myofiber maturation and found that myofibrils (visualized by co-
staining with a-actinin and F-actin) were already formed 5 days
after agrin addition (Supplementary Fig S1C). Therefore, our in
vitro conditions were sufficient to generate mature myofibers with
peripheral nuclei as well as T-tubules and SR organized in striated
transversal triads.
Amph2, dynamin 2, and myotubularin are involved in the
peripheral positioning of nuclei and triad organization
Amph2 is involved in the formation of T-tubules and is localized to
transversal triads in adult myofibers (Butler et al, 1997; Lee et al,
2002). We investigated the localization of amph2 in in vitro myofi-
bers 10 days after agrin addition. We observed that amph2 was
organized in tubular structures both longitudinally and transversally
throughout myofibers (Fig 2A and B). These structures co-localized
with RyR1, found at the junctional SR (Zalk et al, 2007) and caveo-
lin-3, found at the T-tubules and sarcolemma (Parton et al, 1997).
Thus, amph2 also localizes to the organized striated triads in newly
differentiated myofibers.
To determine a role for amph2 in nuclear positioning and trans-
versal triad organization during myofiber differentiation, we trans-
fected myoblasts with Amph2 exon 3 siRNA, Amph2 exon 11
siRNA, or GAPDH siRNA (as control) (Fig 2C and D, Supplementary
Figs S2A and S4A). Amph2 exon 3 is expressed in all amph2
isoforms, whereas Amph2 exon 11 is specifically expressed in skele-
tal muscle isoforms (Nicot et al, 2007). Upon transfection,
myoblasts were differentiated into myotubes and agrin was added
24 h after (Supplementary Fig S1A). Ten days after agrin addition,
the number of nuclei per myofiber (fusion index) was similar in all
experimental conditions (Supplementary Fig S2P). The levels of
amph2 expression were strongly reduced in both Amph2 exon 3
and exon 11 siRNA when compared to GAPDH siRNA (Supplemen-
tary Figs S2A–C and S4A). We found that nuclear positioning at the
myofiber periphery, formation of transversal triads, and myofiber
thickness were significantly inhibited in either Amph2 exon3 or
exon11 siRNAs when compared to non-transfected or GAPDH
siRNA transfected myofibers (Fig 2C, D, G–I and Supplementary Fig
S4A–C). Reducing the expression of dynamin 2 and myotubularin,
encoded by genes mutated in CNM, also leads to a decrease in
peripheral nuclei, myofibers with organized triads and myofiber
thickness (Supplementary Fig S2D–O).
To study whether amph2 was involved in the regulation of
myofibrillogenesis, we examined the morphology of myofibrils and
found no differences between Amph2 siRNA myofibers and
GAPDH siRNA myofibers (Fig 2E and F). We also evaluated the
microtubule cytoskeleton in Amph2 siRNA myofibers, since micro-
tubules are involved in nuclear positioning (Metzger et al, 2012).
We did not observe any changes in the morphology of microtu-
bules and in the expression of b-tubulin on Amph2 siRNA myofi-
bers when compared with GAPDH siRNA (Supplementary Fig
S1D–G).
Alterations in triad structure and organization have been related
to defects in intracellular calcium homeostasis after membrane
depolarization (Powell et al, 1996). A role for amph2 in calcium
homeostasis has been described in isolated muscle fibers after
Amph2 shRNA electroporation in vivo (Tjondrokoesoemo et al,
2011). To determine whether amph2 is also involved in calcium
homeostasis during myofiber formation, we measured cytoplasmic
calcium concentration in myofibers 10 days after agrin addition,
using a fluorescent Fluo-4 direct calcium sensor (Taneike et al,
2011). We observed a reduction of cytoplasmic calcium influx after
KCl-induced membrane depolarization or caffeine-induced calcium
release from the sarcoplasmic reticulum in Amph2 siRNA myofi-
bers, when compared to GAPDH siRNA (Supplementary Fig S3A–C).
These results suggest that amph2 is involved in calcium homeosta-
sis during myofiber formation,
Finally, we tested the role of AMPH2 mutations (associated with
ARCNM) in nuclear positioning and triad organization. We trans-
fected myotubes with cDNA encoding GFP-tagged amph2 mutated
in the BAR domain (amph2 R154Q) and in the SH3 domain
(amph2 K575X) (Toussaint et al, 2011). We found that expression
of either R154Q or K575X amph2 mutants inhibited nuclear posi-
tioning at the periphery of myofibers and disrupted the organiza-
tion of DHPR (Supplementary Fig S3D–G). We also observed a
decrease in the thickness of the myofibers transfected with amph2
R154Q or amph2 K575X when compared to the GFP-transfected
controls (Supplementary Fig S3H). Overall, these results reveal that
amph2, dynamin 2, and myotubularin regulate nuclear peripheral
positioning and triad organization during myofiber formation and
that these functions are also disrupted by mutations in amph2
associated with ARCNM.
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N-WASP associates with amph2 in myofibers and is involved in
nuclear localization and triad organization
N-WASP interacts and regulates amphiphysin orthologs in D. mela-
nogaster and S. cerevisiae, and amphiphysin-1 in mammalian brain
(Madania et al, 1999; Salazar et al, 2003; Zelhof & Hardy, 2004;
Yamada et al, 2009). Thus, we hypothesized that N-WASP could
interact with amph2 in skeletal muscle and play a role in myofiber
maturation and amph2-dependent ARCNM phenotype. We found
that N-WASP co-immunoprecipitated with endogenous amph2 from
extracts of mouse primary mature myofibers and C2C12 myotubes
(Fig 3A and B). Conversely, amph2 co-immunoprecipitated with
C D
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Figure 2. Amph2 is required for triad formation and peripheral localization of nuclei in in vitro myofibers.
A Representative immunofluorescence images of WT primary myofibers treated with agrin for 10 days and immunostained for amph2 (red), RyR (green), and DAPI
(blue). Bar, 15 lm.
B Representative immunofluorescence images of WT primary myofibers treated with agrin for 10 days and immunostained for amph2 (red), Cav3 (green), and DAPI
(blue). Bar, 15 lm.
C Representative immunofluorescence images of WT primary myofibers transfected with GAPDH siRNA, treated with agrin for 10 days, and immunostained for DHPR
(red), triadin (green), and DAPI (blue). On the right 2× magnifications of rectangles. Bar, 15 lm.
D Representative immunofluorescence images of WT primary myofibers transfected with Amph2 siRNA, treated with agrin for 10 days, and immunostained for DHPR
(red), triadin (green), and DAPI (blue). On the right 2× magnifications of rectangles. Bars, 15 lm.
E Representative immunofluorescence images of WT primary myofibers transfected with GAPDH siRNA, treated with agrin for 10 days, and immunostained for
a-actinin (red), F-Actin (green). Bar, 15 lm.
F Representative immunofluorescence images of WT primary myofibers transfected with Amph2 siRNA, treated with agrin for 10 days, and immunostained for
a-actinin (red), F-Actin (green). Bar, 15 lm.
G Quantification of peripheral nuclei in myofibers transfected with GAPDH, Amph2 siRNA, or Amph2 ex11 siRNA, and treated with agrin for 10 days. Error bars, s.e.m.,
n = 3. P-values from t-test (GAPDH siRNA versus Amph2 siRNA condition).
H Quantification of transversal triads in myofibers transfected with GAPDH, Amph2 siRNA, or Amph2 ex11 siRNA and treated with agrin for 10 days. Error bars, s.e.m.,
n = 3. P-values from t-test (GAPDH siRNA versus Amph2 siRNA condition).
I Quantification of myofiber thickness in GAPDH siRNA, Amph2 siRNA, or Amph2 ex11 siRNA and treated with agrin for 10 days. Error bars, s.e.m., n = 3. P-values from
t-test (GAPDH siRNA versus Amph2 siRNA condition).
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endogenous N-WASP from extracts of primary mature myofibers
(Fig 3C). To identify the amph2 domain involved in the interaction
with N-WASP, we expressed GFP-tagged full-length human amph2,
SH3, or BAR domains of amph2 in C2C12 myoblasts (Fig 3D). We
observed that GFP antibodies co-immunoprecipitated endogenous
N-WASP together with amph2 SH3 domain or full-length amph2
(Fig 3F). We observed a very weak signal in BAR domain amph2
after co-immunoprecipitation, probably due to dimerization amph2
via the BAR domain (Lee et al, 2002; Friesen et al, 2006). In addi-






Figure 3. Amph2 interacts with N-WASP and the interaction is disrupted by CNM-associated amph2 mutations.
A Western blot with N-WASP and amph2 antibodies of endogenous amph2 immunoprecipitation in primary myofibers, treated with agrin for 10 days.
B Western blot with N-WASP and amph2 antibodies of endogenous amph2 immunoprecipitation in mouse muscle or C2C12 myotubes.
C Western blot with N-WASP and amph2 antibodies of endogenous N-WASP immunoprecipitation in primary myofibers.
D Diagrams of the amph2 constructs used in (F). All constructs are N-terminally tagged with GFP. Numbers are amino acid position.
E Diagrams of the amph2 full-length CNM mutants used in (G). Point mutation position is highlighted by a star. All constructs are N-terminal tagged with GFP.
F, G Western blot with N-WASP and GFP antibodies of GFP immunoprecipitation in C2C12 cells expressing the indicated constructs.
H GST pull down of N-WASP using the indicated GST-tagged amph2 proteins from muscle homogenates (top) or in vitro transcribed/translated GFP-N-WASP (middle).
Coomassie blue staining of loaded gel is shown at the bottom.
Source data are available online for this figure.
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domains of amph2 and found that the SH3 domain and the full-
length amph2 pulled down N-WASP from muscle homogenates or
from in vitro transcribed/translated GFP-N-WASP (Fig 3H). These
results demonstrate that the SH3 domain of amph2 associates with
N-WASP in skeletal muscle and that likely this interaction is direct.
We next tested whether the AMPH2 mutations found in ARCNM
patients could disrupt the interaction of amph2 with N-WASP. We
expressed human GFP-tagged amph2 with BAR domain mutations
(D151N and R154Q) or SH3 domain mutations (Q573X and K575X)
in C2C12 cells (Fig 3E). We observed that amph2 with BAR domain
mutations co-immunoprecipitated with the same amount of
N-WASP as full-length amph2 (Fig 3G). In contrast, amph2 SH3
mutation Q573X and amph2-K575X did not co-immunoprecipitate
with endogenous N-WASP. In addition, we expressed and purified
GST-tagged amph2 SH3 domain with the same Q573X and K575X
mutations and found that these proteins did not pull down N-WASP
from muscle homogenates or from in vitro transcribed/translated
GFP-N-WASP, except for SH3-K575X that pulled down a residual
amount of in vitro transcribed/translated GFP-N-WASP (Fig 3H).
Finally, we tested the role of N-WASP on peripheral positioning
of nuclei and triad organization during myofiber differentiation. We
efficiently reduced the levels of N-WASP in myotubes using siRNA
without observing any changes in fusion index when compared with
GAPDH siRNA (Supplementary Figs S2P and S3I and J). We observed
a reduction of peripheral nuclear positioning, triad organization,
and myofiber thickness in N-WASP siRNA myofibers (Fig 4A, B, E–
G). Myofibrils morphology was not affected when compared to
GAPDH siRNA myofibers (Fig 4C and D). Altogether, these results
suggest a role for N-WASP in peripheral nuclei positioning and triad
organization, probably mediated by N-WASP interaction with
amph2. Moreover, the disruption of amph2 and N-WASP interaction
by SH3 domain mutations found in ARCNM suggests that alteration
of N-WASP function participates in the etiology of the disease.
N-WASP functions downstream of amph2 to regulate nuclear
localization and triad organization
Our results demonstrating a physical interaction between amph2 and
N-WASP in myofibers, and the similar phenotypes observed when
N-WASP or amph2 are depleted in myofibers, suggest that N-WASP
functions together with amph2 to regulate peripheral nuclear locali-
zation and triad organization. N-WASP activity is modulated by the
switch from an auto-inhibited configuration to an activated state by
different mechanisms; among them is the binding of SH3 domains to
the polypro region of N-WASP. Once activated, the C-terminal VCA
domain of N-WASP interacts with the Arp2/3 complex, leading to
actin polymerization (Prehoda et al, 2000; Padrick & Rosen, 2010).
To determine whether N-WASP functions downstream of amph2, we
expressed full-length N-WASP or the constitutively active VCA
domain of N-WASP in Amph2 or GAPDH siRNA myotubes. After
10 days of differentiation in the presence of agrin, we found that
expression of the VCA domain of N-WASP in Amph2 exon 3 or exon
11 siRNA myofibers restored peripheral localization of nuclei, triad
organization as well as myofiber thickness to the same level as the
GAPDH siRNA (Fig 5A, B, E–G and Supplementary Fig S4A–C).
Expression of full-length N-WASP or GFP in Amph2 siRNA myofi-
bers was not able to restore any of these phenotypes, suggesting that
amph2 is required to activate N-WASP. Furthermore, the expression
of either GFP, full-length N-WASP, or VCA domain in GAPDH siRNA
myofibers did not interfere with peripheral localization of nuclei,
triad organization, or myofiber thickness (Fig 5A, E–G, and Supple-
mentary Fig S4B and C). To rule out that the rescue effect we
observed upon GFP-VCA expression in Amph2 siRNA myofibers was
not due to an indirect role of N-WASP on gene expression (Wu et al,
2006), we tagged the VCA domain with TdTomato (TdT-VCA), a 60-kD
fluorescent protein, to prevent the accumulation of the VCA domain
in the nucleus (Supplementary Fig S4D). We found that expression
of TdT-VCA in Amph2 siRNA myofibers also restored peripheral
localization of nuclei and triad organization (Supplementary Fig S4E
and F). Furthermore, we observed that amph2 was not detectable by
Western blot or immunofluorescence analysis in myofibers transfected
with GFP-VCA and Amph2 exon 3 or exon 11 siRNA (Fig 5C and D,
and Supplementary Fig S4A). Therefore, expression of VCA does not
induce expression of amph2 in Amph2 siRNA myofibers. Finally, we
also tested whether N-WASP could function downstream of myotu-
bularin and dynamin 2. We expressed GFP-VCA in myofibers
depleted for myotubularin or dynamin 2. We found that GFP-VCA
expression rescued peripheral nuclear positioning and triad organi-
zation in dynamin 2 siRNA myofibers, but not myotubularin siRNA
myofibers (Supplementary Fig S2M and N).
Overall, these results indicate that N-WASP functions down-
stream of amph2 and dynamin 2 to regulate peripheral nuclear locali-
zation and triad organization formation during myofiber maturation.
Nuclear localization and triad organization are regulated by
independent pathways
Our results suggest that nuclear positioning at the periphery of the
myofiber is dependent on N-WASP. We next decided to investigate
how N-WASP controls peripheral nuclear positioning. We previ-
ously showed that the spreading of nuclei along the myofibers is
dependent on a conserved mechanism involving Map7, a microtubule-
binding protein, Kif5b, a kinesin, and microtubules (Metzger et al,
2012). Thus, since spreading of nuclei along the myofibers precedes
peripheral nuclear positioning (Fig 1A), we therefore explored the
involvement of Map7/Kif5b/microtubule pathway on nuclear posi-
tioning at the periphery of myofibers and triad organization. We
measured peripheral nuclear position and triad organization in
myofibers depleted for Map7 and Kif5b using siRNA. We observed
that nuclei in Map7 and Kif5b siRNA myofibers were not spread
along the myofibers as we previously described (Fig 6B and C)
(Metzger et al, 2012; Wang et al, 2013). We also found that periph-
eral nuclear positioning and myofiber thickness were reduced in
Map7 and Kif5b siRNA myofibers. Remarkably, triad organization
was not impaired (Fig 6A–F).
At day 5 after agrin addition, nuclei in the myofibers are already
spread along the myofiber, but are not yet positioned at the periph-
ery of the myofiber (Fig 1A–C, Supplementary Movie S1). Thus, the
inhibition of peripheral nuclear positioning could be due to an
impairment of the spreading of nuclei along the myofiber or due to
the direct involvement of the Map7/Kif5b/microtubule pathway on
peripheral nuclear positioning. To distinguish between these two
hypothesis, we treated myofibers at day 5 after agrin addition with
low dose of nocodazole (75 nM), which alters microtubule dynamics
required for microtubule-dependent nuclear movement (Cadot et al,
2012) and allows us to test whether microtubules are directly
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Figure 4. N-WASP is required for peripheral localization of nuclei and triad organization during myofiber formation.
A Representative immunofluorescence images of WT primary myofibers transfected with GAPDH siRNA, treated with agrin for 10 days, and immunostained for DHPR
(red), triadin (green), and DAPI (blue). Bar, 15 lm.
B Representative immunofluorescence images of WT primary myofibers transfected with N-WASP siRNA, treated with agrin for 10 days, and immunostained for DHPR
(red), triadin (green), and DAPI (blue). Bars, 15 lm.
C Representative immunofluorescence images of WT primary myofibers transfected with GAPDH siRNA, treated with agrin for 10 days, and immunostained for
a-actinin (red) and F-Actin (green). Bar, 15 lm.
D Representative immunofluorescence images of WT primary myofibers transfected with N-WASP siRNA, treated with agrin for 10 days, and immunostained for
a-actinin (red) and F-Actin (green). Bar, 15 lm.
E Quantification of peripheral nuclei in myofibers transfected with GAPDH or N-WASP siRNA and treated with agrin for 10 days. Error bars, s.e.m., n = 3. P-values from
t-test.
F Quantification of transversal triads in myofibers transfected with GAPDH or N-WASP siRNA and treated with agrin for 10 days. Error bars, s.e.m., n = 3. P-values from
t-test.
G Quantification of myofiber thickness in myofibers transfected with GAPDH or N-WASP siRNA and treated with agrin for 10 days. Error bars, s.e.m., n = 3. P-values from
t-test.
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involved in peripheral nuclear positioning. We found that inhibition
of microtubule dynamics after day 5 of agrin addition did not prevent
peripheral nuclear positioning (Fig 6H and J). We also did not
observe any alterations in triad organization or myofiber thickness
(Fig 6K and L). Overall, these results suggest that peripheral nuclear
positioning is not dependent on microtubules but requires Map7/
Kif5b/microtubule-dependent spreading of nuclei along the myofiber
prior to nuclear positioning at the periphery of the fiber. Further-
more, triad organization is not dependent on nuclear positioning.
Our results suggest that nuclear positioning at the periphery of
the myofiber is dependent on N-WASP, an actin regulator (Fig 4).
Nesprins are a class of KASH-domain nuclear envelope proteins that
bind to actin and are involved in the position of the nucleus in
matured myofibers (Grady et al, 2005). We previously showed that
the spreading of nuclei along myofibers is independent of nesprins,
therefore nesprins are probably involved in nuclear positioning
events that occur after nuclei spreading in the myofibers (Metzger
et al, 2012). To test this hypothesis, we expressed in myoblasts a
dominant-negative KASH construct (SR-KASH) that removes KASH
proteins from the nuclear envelope and disrupts the connection
between the nucleus and the actin cytoskeleton (Grady et al, 2005).
We also expressed a control KASH construct lacking the C-terminal
region required for nuclear envelope anchoring (KASHDL) (Luxton
et al, 2010). We observed that expression of SR-KASH inhibited
peripheral nuclear position 10 days after agrin addition, without
any effect on triad organization when compared with control
KASHDL (Fig 6M–P). In addition, expression of SR-KASH induced a
minor, although significant, decrease of myofiber thickness, when
compared with KASHDL (Fig 6Q). These results suggest that nesp-
rins are involved in peripheral nuclear positioning but not in triad
organization. Finally, to determine whether actin is also involved in
peripheral nuclear positioning, we treated myofibers at day 5 after
agrin addition with latrunculin B to impair actin dynamics. We
observed that peripheral nuclear positioning, triad organization, and
fiber thickness were reduced 10 days after agrin addition (Fig 6I–L),
suggesting that actin is involved in peripheral nuclear positioning
and triad organization. Overall, our results demonstrate that periph-
eral nuclear positioning is dependent on the correct spreading of
nuclei along the myofiber driven by Map7/Kif5b/microtubules path-
way, on nesprins and on actin. Furthermore, we show that triad
organization is not dependent on the position of the nucleus at the
periphery of the myofiber.
N-WASP and amph2 are involved in the maintenance of triad
organization in skeletal muscle
Amph2 is localized specifically at striated triads, whereas N-WASP
is mainly found at the Z-line and also in discrete patches between
Z-lines in longitudinal sections of mature muscle fibers (Butler
et al, 1997; Razzaq et al, 2001; Takano et al, 2010) (Supplemen-
tary Fig S5B). Since striated triads are found primarily between
Z-lines (Flucher, 1992) (Supplementary Fig S5D), we hypothesized
that the discrete patches of N-WASP observed between Z-lines
could localize to the triads. We determined the localization of
N-WASP in adult mouse isolated fibers and observed that the
discrete patches of N-WASP co-localized with amph2 and DHPR
(Fig 7A and Supplementary Fig S5C). In transversal sections of
adult mouse and human muscle fibers, we observed strong
co-localization between N-WASP and DHPR (Fig 8 and Supple-
mentary Fig S5A), suggesting that N-WASP is also found at the
triads in mature muscle fibers. Finally, we analyzed human
muscle biopsies by differential centrifugation (Gokhin & Fowler,
2011) and found that N-WASP was present in the same cellular
membrane fractions as amph2 and DHPR (Supplementary Fig S8A
and B). To determine when N-WASP is recruited to the triads, we
analyzed the localization of N-WASP during myofiber formation
in vitro. We found that 10 days after agrin addition, N-WASP
starts to accumulate at the newly formed striated triads (Supple-
mentary Fig S5E). Overall these results strongly suggest that a
pool of N-WASP is also localized to the triads in newly formed
and matured myofibers.
We next determined whether the localization of N-WASP in adult
muscle fibers was dependent on amph2. We electroporated Amph2
or GAPDH siRNA, together with a plasmid encoding the fluorescent
protein TdT, in adult mouse muscle. We collected whole muscle or
isolated single muscle fibers expressing TdT 10 days after electropo-
ration (Supplementary Fig S6A) and immunostained for amph2 and
N-WASP either in muscle sections or in isolated fibers. The distribu-
tion of amph2 and N-WASP was not affected in GAPDH siRNA
muscle sections (Fig 7B and C) or isolated fibers (Supplementary
Fig S6B) compared to non-transfected controls. Importantly,
N-WASP distribution was disrupted in Amph2 depleted myofibers
(Fig 7D and Supplementary Fig S7B) and myofibril morphology was
not altered, as previously reported (Supplementary Fig S7A)
(Toussaint et al, 2011).
We next determined the involvement of N-WASP in the distribu-
tion of amph2. We collected whole muscle and isolated fibers from
muscles electroporated with N-WASP siRNA and observed that
amph2 distribution was disrupted (Fig 7E and Supplementary Fig
S6B). No changes in myofibril morphology were detected in N-WASP
siRNA myofibers, when compared to GAPDH siRNA myofibers, as
previously reported (Supplementary Fig S7A) (Takano et al, 2010).
Interestingly, nuclei remained at the periphery of the myofibers
depleted for amph2 and N-WASP, suggesting that these proteins are
not involved in anchoring the nuclei at the periphery of muscle fibers
in adult skeletal muscle at least up to 10 days after electroporation
(data not shown). Finally, we tested the role of AMPH2 ARCNM
mutations on the distribution of N-WASP in adult muscle. We elec-
troporated GFP-tagged amph2 with a BAR domain (D151N) or a SH3
domain (K575X) mutations into adult muscle and isolated single
muscle fibers positive for GFP expression (Supplementary Fig S6C).
We found that both mutations disrupted the localization of N-WASP
(Supplementary Fig S6D). Overall, these results suggest that amph2
is involved in the distribution of N-WASP in muscle. Conversely,
N-WASP is also involved in the distribution of amph2 in muscle.
Our results show that amph2 and N-WASP are involved in the
organization of triads during myofiber maturation (Figs 2 and 4).
Thus, we next determined the involvement of amph2 and N-WASP
in the maintenance of organized triads in adult muscle. We electro-
porated Amph2, N-WASP, or GAPDH siRNA into adult mouse muscle
and analyzed the distribution of DHPR and RyR1 in longitudinal
muscle sections. Knockdown of Amph2 or N-WASP in muscle fibers
leads to disruption of DHPR distribution (Fig 7F and G). RyR1 distri-
bution was also disrupted in N-WASP siRNA fibers but less
disrupted in Amph2 siRNA fibers (Fig 7H and I). We also analyzed
isolated single muscle fibers from muscle transfected with Amph2 or
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N-WASP siRNA and observed a strong alteration of triad organiza-
tion (Fig 7J). These results suggest a role for amph2 and N-WASP
on the maintenance organized triads in adult muscle fibers.
N-WASP distribution and expression is altered in centronuclear
myopathy and myotonic dystrophy
Since our results support a role for N-WASP in amph2-associated
ARCNM, we analyzed the localization of N-WASP in a muscle
biopsy from an ARCNM patient carrying AMPH2 mutation (R154Q),
and compared it to a healthy muscle biopsy. In transversal sections
of healthy muscle biopsy, N-WASP was found in a reticulated struc-
ture that co-localized with DHPR and amph2 (Fig 8A and B).
However, N-WASP organization in ARCNM muscle biopsy was
severely disrupted, with a significant accumulation around the
centrally located nuclei (Fig 8A and B). DHPR and amph2 distribu-
tion was also severely impaired, as previously described (Fig 8A
and B) (Toussaint et al, 2011). Analysis of the same muscle biopsies
by differential centrifugation confirmed the changes in the distribu-
tion of N-WASP, amph2, DHPR, and Cav3, but not a-actinin
(Supplementary Fig S8A and B). We also determined the localization
of N-WASP, amph2, and DHPR in muscle biopsies from ADCNM
and XLCNM patients carrying DNM2 mutation (E368K) and MTM1
mutation (R421InsFIG), respectively (Supplementary Fig S8C–F). In
ADCNM patients, N-WASP, amph2, and DHPR exhibited a more
diffused distribution, with accumulation around the centrally located
nuclei similar to what was observed for ARCNM patients. On the
other hand, the changes in distribution of N-WASP, amph2, and
DHPR between XLCNM and healthy patient biopsies were milder.
The changes in organization of N-WASP could be caused by
alterations of N-WASP expression in muscle. We measured mRNA
levels of N-WASP, DHPR, AMPH2, DNM2, and MTM1 in different
CNM muscle biopsies and did not find any changes when compared
with healthy biopsies (Supplementary Fig S9A), except for MTM1 in
XLCNM, as previously described (Vasli et al, 2012). Next, we
measured protein levels in the same CNM muscle biopsies and
found that N-WASP protein levels were decreased in ARCNM and
ADCNM, but not in XLCNM (Supplementary Fig S9B and C). There-
fore, mutations in AMPH2 and DNM2, but not MTM1, can result in
a reduction of the stability of N-WASP protein.
Amph2 is mis-spliced in myotonic dystrophy of type 1 (DM1), a
muscular dystrophy with histopathological features such as
centrally located nuclei without signs of regeneration, muscle fiber
atrophy and T-tubules alterations, also observed in CNM (Fugier
et al, 2011). Therefore, we analyzed the distribution of N-WASP
and amph2 in transversal section of biopsies from patients with
DM1. We found that N-WASP and amph2 distribution was
disrupted, when compared with a healthy biopsy (Fig 8C). We also
measured the levels of mRNA and did not detect a decrease of
N-WASP, AMPH2, DHPR, DNM2, and MTM1 mRNA in DM1 patient
muscle samples (Supplementary Fig S9A). These results suggest that
N-WASP might also be implicated in DM1 pathology.
Discussion
In this work, we identified a role for N-WASP downstream of amph2
regulating the organization of triads and the position of the nucleus
at the periphery of myofibers. Furthermore, we showed that nuclear
positioning at the periphery of myofibers is dependent on nesprins,
actin and requires prior distribution of nuclei along the myofibers,
driven by microtubules, Map7 and Kif5b. In addition, triad organization
occurs independently of nuclear positioning at the periphery of
myofibers (Fig 8D and E). Finally, we provide evidence for the
disruption of N-WASP function in centronuclear myopathies and
myotonic dystrophies, probably downstream of amph2, suggesting
an impairment of the identified molecular mechanism on these
muscle disorders.
An in vitro system suitable to study molecular mechanisms of
myofiber maturation and muscle disorders
Previous reports described the formation of differentiated myofibers
in vitro. Flucher et al (1994) described the organization of T-tubules
in longitudinal orientation in mouse myotubes, although transversal
organization was occasionally observed and peripheral localization
of nuclei was not assessed. Cusimano et al (2009) observed the
formation of aligned striated triads, but the peripheral localization
of nuclei was not reported. Cooper et al (2004) reported peripheral
positioning of nuclei in mouse myofibers, although triad organization
was not studied. In this manuscript, we report a novel in vitro
system to differentiate mouse myoblasts into mature myofibers with
clearly observable striated transversal triads, myofibrils, and periph-
eral nuclei (Fig 1). The ultrastructure of triads and myofibrils of the
Figure 5. N-WASP involvement downstream of amph2.
A Representative immunofluorescence images of myofibers transfected with GAPDH siRNA and GFP (top), GFP-N-WASP full-length (N-WASP FL, middle) or GFP-VCA
(VCA, bottom), treated with agrin for 10 days, and stained for DHPR (red) and DAPI (blue). Bar, 15 lm.
B Representative immunofluorescence images of myofibers transfected with Amph2 siRNA and GFP (top), GFP-N-WASP (middle), or GFP-VCA (bottom), treated with
agrin for 10 days and stained for DHPR (red) and DAPI (blue). Bar, 15 lm.
C Representative immunofluorescence images of myofibers transfected with GFP-VCA and GAPDH siRNA (top) or Amph2 siRNA (bottom), and stained for amph2 (red)
and DAPI (blue). Bar, 15 lm.
D Western blot with amph2 and b-tubulin antibodies of myofibers transfected with Amph2 siRNA or Amph2 siRNA and GFP-VCA.
E Quantification of peripheral nuclei in myofibers transfected with GAPDH (light blue) or Amph2 (blue) siRNA and with GFP, GFP-N-WASP-FL, or GFP-VCA, and treated
with agrin for 10 days. Error bars, s.e.m., n = 3. P-values from t-test (GFP versus GFP-N-WASP-FL or GFP-VCA).
F Quantification of transversal triads in myofibers transfected with GAPDH (pink) or Amph2 (red) siRNA and with GFP, GFP-N-WASP-FL, or GFP-VCA, and treated with
agrin for 10 days. Error bars, s.e.m., n = 3. P-values from t-test (GFP versus GFP-N-WASP-FL or GFP-VCA).
G Quantification of myofiber thickness in myofibers transfected with GAPDH (light green) or Amph2 (green) siRNA and with GFP and GFP-VCA, and treated with agrin for
10 days. Error bars, s.e.m., P-values from t-test (GFP versus GFP-VCA conditions).
Source data are available online for this figure.
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in vitro myofibers was more developed than myofibers from neona-
tal mouse muscle since most of the triads were already transversally
organized and we rarely observed diads (Ito et al, 2001; Takekura
et al, 2001).
We used this system to identify the role of amph2 and N-WASP
on triad organization and peripheral nuclear positioning, to identify
the mechanism that drives peripheral nuclear positioning, and to
describe that triad organization occurs independently of peripheral
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Figure 6. Role of microtubules and actin in nuclear positioning and triad organization during myofiber maturation.
A–C Representative immunofluorescence images of WT primary myofibers transfected with GAPDH siRNA (A), Map7 siRNA (B), or Kif5b siRNA (C), treated with agrin for
10 days and subsequently immunostained for DHPR (red), triadin (green), and DAPI (blue). Bar, 15 lm.
D Quantification of peripheral nuclei in myofibers transfected with GAPDH, Map7, or Kif5b siRNA. Error bars, s.e.m., n = 3. P-values from t-test.
E Quantification of transversal triads in myofibers transfected with GAPDH, Map7, or Kif5b siRNA. Error bars, s.e.m., n = 3. P-values from t-test.
F Quantification of myofiber thickness in myofibers transfected with GAPDH, Map7, or Kif5b siRNA. Error bars, s.e.m., n = 3. P-values from t-test.
G–I Representative immunofluorescence images of WT primary myofibers untreated (G) or treated with 75 nM of nocodazole (H) or 10 lM of latrunculin B (I) at day 5
after agrin treatment, and immunostained at day 10 for DHPR (red), triadin (green), and DAPI (blue). Bar, 15 lm.
J Quantification of peripheral nuclei in myofibers untreated or treated with nocodazole and latrunculin B as described in (G–I). Error bars, s.e.m., n = 3. P-values
from t-test.
K Quantification of transversal triads in myofibers untreated or treated with nocodazole and latrunculin B as described in (G–I). Error bars, s.e.m., n = 3. P-values
from t-test.
L Quantification of myofiber thickness in myofibers untreated or treated with nocodazole and latrunculin B as described in (G–I). Error bars, s.e.m., n = 3. P-values
from t-test.
M, N Representative immunofluorescence images of WT primary myofibers transfected with RFP-KASHDL (M) and RFP-SR-KASH (N), 10 days after agrin addition
immunostained for triadin (green) and DAPI (blue). Bar, 15 lm.
O Quantification of peripheral nuclei in myofibers transfected with RFP-KASHDL or RFP-SR-KASH as described in (M, N). Error bars, s.e.m., n = 3. P-values from t-test.
P Quantification of transversal triads in myofibers transfected with RFP-KASHDL or RFP-SR-KASH as described in (M, N). Error bars, s.e.m., n = 3. P-values from t-test.
Q Quantification of myofibers thickness in myofibers transfected with RFP-KASHDL or RFP-SR-KASH as described in (M, N). Error bars, s.e.m., n = 3. P-values from t-test.
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nuclear positioning. We also showed that mutations in amph2
associated with ARCNM disrupt the function of amph2 and
N-WASP on nuclear positioning and triad organization. This
system can be used to study molecular mechanisms that occur
during myofiber formation from initial fusion events to later stages
of the establishment of functional transversal triads. Furthermore,
this system provides a platform to screen for potential drugs that
will prevent myofiber defects associated with CNM and other
muscle disorders.
Involvement of amph2 and N-WASP in triad organization
The mechanisms of triad organization and maintenance are poorly
understood. Formation and maintenance of membrane deformation
of the T-tubules could be mediated by the actin cytoskeleton, which
provides the required scaffold to stabilize membrane shape (Suetsugu
& Gautreau, 2012). Amph2, a BAR domain-containing protein, is
involved in T-tubule biogenesis and accumulates to T-tubules (Butler
et al, 1997; Lee et al, 2002; Toussaint et al, 2011). Our data suggest
that the SH3 domain of amph2 forms a complex with N-WASP that
is important for triad organization (Figs 3 and 4). Amph2 is proba-
bly involved in the localization of N-WASP to triads since amph2
BAR domain mutations perturb the distribution of N-WASP without
disrupting the interaction between amph2 and N-WASP (Figs 3G, 8
and Supplementary Fig S6D). In addition, the distribution of
N-WASP in DM1 patient samples is also disturbed probably due to
mislocalization of alternatively spliced amph2 (Fig 8C) (Fugier et al,
2011). We also provide evidence for a role of N-WASP downstream
of amph2 regulating triad organization since we found that expres-
sion of constitutively active N-WASP restored triad organization in
amph2-depleted myofibers (Fig 5 and Supplementary Fig S4).
We propose a model in which amph2 recruits N-WASP to the
vicinity of T-tubules allowing N-WASP to regulate the actin cyto-
skeleton required for structural stability and organization of triads.
The actin cytoskeleton that regulates the organization and mainte-
nance of triads is unknown; however, gamma-actin is a good
candidate. Gamma-actin accumulates in the vicinity of the triads
(Kee et al, 2004, 2009) and co-fractions with SR proteins after
differential centrifugation (Gokhin & Fowler, 2011). In addition,
skeletal muscles of gamma-actin knockout mice progressively
accumulate centrally located nuclei without any signs of regenera-
tion (damaged sarcolemma, inflammation, and fibrosis), which is
similar to what can be observed in CNM (Biancalana et al, 2003;
Sonnemann et al, 2006; Al-Qusairi et al, 2009). In our model,
N-WASP might regulate this pool of gamma-actin via the Arp2/3
complex or/and nebulin (Prehoda et al, 2000; Takano et al,
2010). Furthermore, tropomyosin Tm5NM1 was described to accu-
mulate specifically at the triads, and Tm5NM1 knockout mice
show defects in triad organization and EC coupling (Vlahovich
et al, 2009). Tropomyosins are involved in actin filaments stabil-
ization; therefore, we speculate that an equilibrium between actin
dynamics regulated by N-WASP and actin stabilization regulated
by tropomyosin might be involved in triad organization and main-
tenance, similar to what is observed in lamellipodium-based cell
motility (Bugyi et al, 2010). N-WASP was recently found to regu-
late the polymerization of alpha-actin at the Z-lines of myofibrils
(Takano et al, 2010). N-WASP is not required for the formation of
myofibrils, however, is involved in myofibril maturation and
myofiber growth (Takano et al, 2010) (Fig 4C, D and G). There-
fore, we speculate that N-WASP could regulate two independent
pools of actin (alpha and gamma) in two different myofiber struc-
tures (Z-lines and triads). A similar mechanism is probably pres-
ent in cardiac muscle where an amph2-specific isoform is
involved in T-tubule morphology (Hong et al, 2014). Future
experiments in cardiac muscle should provide evidence for an
interaction between amph2 and N-WASP and a role for N-WASP
on T-tubule morphology.
Molecular mechanism of nuclear positioning during
myofiber formation
Nuclei are positioned at the periphery during myofiber differentia-
tion, a process which is highly regulated (Bruusgaard et al, 2003;
Starr & Fridolfsson, 2010). We can deduce that peripheral nuclear
positioning during myofiber maturation is not simply the conse-
quence of unspecific peripheral pushing forces due to sarcomere
formation because: (1) sarcomeres are formed prior to peripheral
nuclear positioning and (2) we do not observe any defects on
sarcomere morphology when peripheral nuclear positioning is
inhibited (Figs 2, 4 and 6). Several mechanisms dependent on
actin-binding proteins of the nuclear envelope (nesprins) and
microtubules influence nuclear positioning during skeletal muscle
differentiation (Zhang et al, 2007; Metzger et al, 2012). In this
work, we establish that peripheral nuclear position requires two
separate steps. First, nuclei must spread along the myofiber by a
microtubule/Map7/Kif5b-dependent mechanism (Metzger et al,
2012). Second, nuclear movement to the periphery is dependent
on amph2, N-WASP, actin, and nesprins (Fig 8D and E). Therefore,
a switch from a microtubule-driven to an actin-driven nuclear
positioning mechanism probably occurs during skeletal muscle
differentiation. Finally, our results suggest that amph2, N-WASP,
and actin are involved in both formation of triads and peripheral
nuclear positioning. However, microtubules, Map7, Kif5, and nesp-
rins are mainly involved in peripheral nuclear positioning with no
identifiable role on the formation of triads.
Amph2 and N-WASP involvement in muscle diseases
Centronuclear myopathies are characterized by centrally located
nuclei and defects in T-tubules, triads, and excitation–contraction
coupling (Al-Qusairi et al, 2009; Dowling et al, 2009; Toussaint et al,
2011). Our results strongly suggest that mutations in AMPH2 and
DNM2, but not MTM1, prevent N-WASP from accumulating at triads
(Fig 8). A common molecular mechanism may thus link amph2 and
dynamin 2 with N-WASP, as previously proposed (Cowling et al,
2012). N-WASP function in CNM is probably impaired by disruption
of N-WASP targeting to the membranes of T-tubules due to muta-
tions in AMPH2 hampering either the association of N-WASP to
amph2 or the association of the N-WASP–amph2 complex to
membranes. How mutations in DNM2 lead to disruption of amph2
and N-WASP localization and function is currently unknown.
AMPH2 mRNA splicing is misregulated in skeletal muscle of
myotonic dystrophy patients leading to the expression of amph2
lacking the phosphoinositide-binding (PI) domain encoded by
exon 11, which is involved in the targeting of AMPH2 to triads (Lee
et al, 2002; Fugier et al, 2011). Amph2 splicing misregulation is
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associated with the disorganization of triads observed in myotonic
dystrophy skeletal muscles. Interestingly, our data suggest that N-
WASP is also involved in DM1 pathology since we observed a
disruption of the localization of N-WASP on DM1 muscle, as previ-
ously reported for amph2 (Fig 8C) (Fugier et al, 2011). Therefore,
misregulation of N-WASP function might also underlie the impair-
ment of muscle function in myotonic dystrophy.
Finally, we showed that expression of active N-WASP (VCA
domain) can revert the defects on nuclear positioning and triad
organization caused by downregulation of amph2 or dynamin-2
(Fig 5 and Supplementary Fig S4). Therefore, activation of N-WASP
in skeletal muscle might improve muscle function in patients with
centronuclear myopathy, myotonic dystrophy, and other multiple
muscle disorders characterized by defects in nuclear positioning and
triad organization (Cowling et al, 2012).
Materials and Methods
Antibodies
The following antibodies were used: mouse anti-DHPR (IF) 1:500
from Chemicon; rabbit anti-triadin (TRISK95) (IF) 1:500 is described
in (Marty et al, 2000); mouse anti-amph2 clone 99D (Upstate) (IF)
1:200; (WB) 1:1,000; (IP) 2 µg, and rabbit anti-amph2 2406 (WB)
1:1,000 is described in (Toussaint et al, 2011); rabbit anti-N-WASP
from EMC (IF) 1:200 and (WB) 1:1,000 for and mouse anti-N-WASP
from Sigma (IF) 1:200; (WB) 1:1,000; (IP) 10 µg; mouse anti-RyR from
Sigma (IF) 1:200; mouse anti-GAPDH (WB) 1:5,000 (IF) 1:500 from
Ambion; mouse anti-beta-tubulin (WB) 1:1,000 from Sigma; mouse
anti-actinin EA53 from Sigma (IF) 1:800; rabbit anti-calnexin from
Abcam (WB) 1:2,000. Anti-tubulin (IF) 1:50 (from rat monoclonal
anti-a-tubulin (YL1/2)-producing hybridoma cell line, ATCC).
Plasmids and siRNA
GFP-tagged human amph2-K573X, amph2-K575X, amph2-D151N,
and amph2-R154Q were described in (Nicot et al, 2007). GFP-tagged
N-WASP-FL or VCA (Lommel et al, 2001) were a gift from Theresia
Stradal. pTdT-VCA has been generated by NheI-BsrGI replacement of
GFP with pTdT in GFP-VCA. pcDNA GFP was a gift from Alexis Gaut-
reau. RFP-KASHDL and RFP-SR-KASH were previously described in
(Luxton et al, 2010). The following siRNAs were purchased from Life
Technologies; amph2 exon3 siRNA (GGAUCUUCGGACCUAUCUGtt);
N-WASP siRNAs (#1: GGCUAAUCCACUCUGAGUAtt and #2: GGC
UAUUUUUUAGCAAAGAtt); GAPDH siRNA (cat # AM4624); DNM2
siRNA (GCGAAUUGAAGGCUCGGGAtt),MTM1 siRNA (CGCAUAUCA
AACUCAGAAtt), amph2 exon11 siRNA (CGGCUGCGCAGAAAGAAG-
Att), Kif5b siRNA (TAGACCGGATAAAGGAAGCAG), and Map7
siRNA (CAGAUUAGAUGUCACCAAUTT).
Western blotting
Cells were lysed in PBS + 1% SDS and passed through a Qiashredder
column (Qiagen) to disrupt DNA. For human muscle, protein
extracts were obtained from 200–300 sections from each biopsie and
lysed in RIPA buffer.
Protein concentration was measured with a BCA kit according to
manufacturer instructions (Pierce). Equal amount of sample were
boiled in 30 µl sample buffer and were loaded on 4–12% precast
Bis-Tris gel (Invitrogen) and transferred into nitrocellulose
membrane using the iBlot apparatus (Invitrogen). Membranes were
blocked with blocking buffer (5% non-fat dry milk, 0.1% Tween in
TBS). Primary antibodies were incubated overnight in blocking
buffer at 4°C. After three washes with TBS-Tween 0.1%,
membranes were incubated with HRP-conjugated secondary
antibodies (1 h at room temperature). Proteins were visualized
using ECL reagent (Pierce).
PCR
After lysis with RIPA buffer, the sample were divided in two parts,
one were precipitated with acidic phenol/chloroform (pH 4.5) for
RNA extraction and the other were used for differential centrifuga-
tion followed by Western blot as described before. cDNAs were
synthesised from 2 to 5 lg of total RNA using Superscript II reverse
Figure 7. N-WASP and amph2 localization in adult muscle and its role on the maintenance of triad organization.
A Left panel: representative immunofluorescence images of isolated WT mouse muscle fibers immunostained for amph2 (red) or N-WASP (green). Right panel: line-scan
of indicated region in the left panels showing average intensity of N-WASP (green) and amph2 (red), respectively. Bar, 1 lm.
B Representative immunofluorescence images of longitudinal sections of WT mouse muscle electroporated with GAPDH siRNA and immunostained after 10 days for
GAPDH (red) and amph2 (green). A star indicates a myofiber depleted for GAPDH. Bar, 50 lm.
C Representative immunofluorescence images of longitudinal sections of WT mouse muscle electroporated with GAPDH siRNA and immunostained after 10 days for
GAPDH (red) and N-WASP (green). A star indicates a myofiber depleted for GAPDH. Bar, 50 lm.
D Representative immunofluorescence images of longitudinal sections of WT mouse muscle electroporated with Amph2 siRNA and immunostained after 10 days for
amph2 (red), N-WASP (green). A star indicates a myofiber depleted for amph2. Bar, 50 lm.
E Representative immunofluorescence images of longitudinal sections of WT mouse muscle electroporated with N-WASP siRNA and immunostained after 10 days for
N-WASP (red), and amph2 (green). A star indicates a myofiber depleted for N-WASP. Bar, 50 lm.
F Representative immunofluorescence images of longitudinal sections of WT mouse muscle electroporated with Amph2 siRNA and immunostained after 10 days for
amph2 (red), DHPR (green). A star indicates a myofiber depleted for amph2. Bar, 50 lm.
G Representative immunofluorescence images of longitudinal sections of WT mouse muscle electroporated with N-WASP siRNA and immunostained after 10 days for,
N-WASP (red) and DHPR (green). A star indicates a myofiber depleted for N-WASP. Bar, 50 lm.
H Representative immunofluorescence images of longitudinal sections of WT mouse muscle electroporated with Amph2 siRNA and immunostained after 10 days for
amph2 (red) and RyR (green). A star indicates a myofiber depleted for amph2. Bar, 50 lm.
I Representative immunofluorescence images of longitudinal sections of WT mouse muscle electroporated with N-WASP siRNA and immunostained after 10 days for
N-WASP (red), and RyR (green). A star indicates a myofiber depleted for N-WASP. Bar, 50 lm.
J Left panels: representative immunofluorescence images of isolated mouse muscle fibers, immunostained for triadin (red) and DHPR (green) in GAPDH siRNA, Amph2
siRNA, and N-WASP siRNA electroporated fibers, respectively. Right panel: line-scan of indicated regions in the left panel showing average intensity of N-WASP
staining (green) compared to amph2 (red), respectively. Bar, 1 lm.
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transcriptase (Invitrogen) and random hexamers. Quantitative PCR
amplification of cDNAs was performed on Light Cycler 480 and Light
Cycler 24 instruments (Roche) using 58°C as melting temperature.
Primers used were DHPRa1S (CACNA1S) (F-GCTACTTTGGA-
GACCCCTGGAA, R-CAGAAGGAGTGCGAACCCTCCT), N-Wasp (WASL)
(F-CAGAGGCACAACTTAAAGACAGAG, R-CTCCTTCCAGGCCAAG
TGTAG), MTM1 (F- TGGAAGAATACAGGAGGC, R- TGGAATTCGAT
TTCGGGAC) BIN1 (F-TCTCCAGAAGCTGGGGAAG, R-TGACTTGAT
GTCGGGGAACT), DNM2 (F-GAGTTTGACGAGAAGGACTTA, R- GA
TTAGCTCCTGGATAACCAG), and 18S (F-CGCCGCTAGAGGTGAA-
ATTC, R-TTGGCAAATGCTTTCGCTC).
Immunoprecipitation
For immunoprecipitation of endogenous N-WASP or amph2, anti-N-
WASP mAb or anti-amph2 mAb were cross-linked to magnetic
Dynabeads protein G (Invitrogen) using BS3 linker (Fisher Scien-
tific) following manufacturer instructions. Cells were lysed in RIPA
buffer, centrifuged at 2,650 g for 5 min, and cell lysates were precle-
ared with dynabeads for 30 min at 4°C. Supernatants were incu-
bated with the antibody-coupled Dynabeads for 60 min at 4°C,
washed with RIPA buffer, and dynabeads were boiled in 20 µl of
sample buffer and analyzed by Western blot. For immunoprecipita-
tion of GFP-tagged proteins, a GFP-Trap system (Chromotek) was
used following manufacturer instructions. After thorough washing
with the lysis buffer, bound proteins were eluted in sample buffer
boiled and analyzed by Western blot.
For immunoprecipitation in muscle, fresh mouse tibialis anterior
muscles (8 weeks old) were dissected and homogenized with a
dounce homogenizer in ice-cold co-IP buffer (50 mM Tris-Cl, pH
7.5; 100 mM NaCl; 5 mM EDTA; 5 mM EGTA; 1 mM DTT; 0.5%
Triton X-100; and 2 mM PMSF) supplemented with 0.05% (w/v)
A B
C D E
Figure 8. N-WASP and amph2 localization in muscle from healthy and ARCNM patients.
A Representative immunofluorescence images of transversal sections of human muscle from healthy donor (top) or ARCNM patient carrying AMPH2 R154Q mutation,
immunostained for DHPR (red), N-WASP (green), and DAPI (blue). Bars, 15 lm.
B Representative immunofluorescence images of transversal sections of human muscle from healthy donor (top) or ARCNM patient carrying AMPH2 R154Q mutation,
immunostained for amph2 (red), N-WASP (green), and DAPI (blue). Bars, 15 lm.
C Representative immunofluorescence images of transversal sections of human muscle from healthy donor (top) or DM1 patient, immunostained for amph2 (red),
N-WASP (green), and DAPI (blue). Bars, 15 lm.
D Schematic representation of the pathways that regulate triad organization and peripheral nuclear position downstream of amph2 and N-Wasp.
E Model for peripheral nuclear positioning during myofiber formation. After fusion of myoblast, nuclei (red) of myotubes cluster in the center of the myotube before
nuclear spreading. After nuclei spread along the myotube, they become peripheral located at the myofiber periphery.
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SDS. Lysates were centrifuged at 14,000 g at 4°C and precleared
with 50 ll of G-sepharose beads (GE Healthcare) and subsequently
incubated with antibodies of interest for 12–24 h at 4°C. Protein
G-sepharose beads (50 ml) were then added for 4 h at 4°C to
capture the immune complexes. Beads were washed four times with
co-IP buffer and one time with high stringency co-IP buffer (with
300 mM NaCl). For all experiments, two negative controls consisted
of a sample lacking the primary antibody (Beads) and a sample
incubated with IgG antibody (IGBMC, Illkirch, France). Resulting
immune-bound complexes were eluted in Laemmli buffer and
submitted to SDS-PAGE and Western blot analysis.
GST pull down and in vitro transcription/translation
cDNA corresponding to full-length, BAR+PI, BAR (aa 1–255), and
SH3 (aa 380–454) sequences of BIN1 (isoform 8, 454 aa) and to full-
length sequence of MTM1 were cloned into pENTR1A Gateway
entry vector (Invitrogen) and recombined into pDEST15 (N-ter GST
fusion) destination vectors. Mutations were introduced in
pENTR1A-BIN1 full-length vector using primer-directed PCR muta-
genesis. All the constructs were verified by Sanger sequencing. GST
fusion proteins were expressed in the E. coli strain BL21-Rosetta 2
(Novagen). Recombinant proteins were extracted from bacterial
pellets by adding extraction buffer (50 mM Tris-HCl (pH 8.0),
100 mM NaCl, 5 mM EDTA, 1 mM EDTA) supplemented with
1 mg/ml lysosyme, a cocktail of protease inhibitors (Complete
EDTA free, Roche) and 1 mM PMSF. After 30 min incubation on
ice, detergents were added (0.01% N-laurylsarcosine and 0.5%
Triton X-100) and lysates were incubated overnight at 4°C to obtain
high solubilization. Then, lysates were centrifuged at 16,000 g for
30 min. GST fusion proteins were purified by incubation with
glutathione sepharose 4B beads (GE Healthcare) overnight
followed by extensive washing with extraction buffer plus 0.5%
Triton X-100.
The purified GST fusion proteins coupled to glutathione beads
were then incubated overnight with N-WASP translated in vitro
(TNT Coupled Reticulocyte Lysate Systems, Promega) according to
the manufacturer’s protocol. Briefly, pEGFP-N-WASP plasmid was
incubated with Methionine and TNT T7 quick master mix for 2 h
at 30°C. The homogenates were diluted with extraction buffer
50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 5 mM EDTA, 1 mM
EDTA) supplemented with a cocktail of protease inhibitors (Com-
plete EDTA free, Roche) and 1 mM PMSF. After washing beads
several times with extraction buffer, bound proteins were analyzed
by Western blot.
Muscle homogenate differential centrifugation
Differential centrifugation of muscle from control and ARCNM biop-
sies homogenates have been used to obtain different fractions. The
homogenate was centrifuged at 1,500 g for 5 min at 4°C, producing
a low-speed pellet rich in myofibrils (1,500 g pellet). After washing
the low-speed pellet four times in rigor buffer, the low-speed super-
natant was centrifuged at 15,000 g for 15 min at 4°C, producing a
medium-speed pellet rich in organelles, membranes, and other
extrasarcomeric structures (15,000 g pellet). The resulting medium-
speed supernatant was then centrifuged at 150,000 g for 15 min
at 4°C, producing a high-speed pellet rich in microsomes and
macromolecular complexes (150,000 g pellet) and a high-speed
supernatant containing cytosol.
Cell culture, reagents, and TA muscle fiber isolation
All procedures using animals were approved by the Institutional
ethics committee and followed the guidelines of the National
Research Council Guide for the care and use of laboratory animals.
Primary myoblasts from WT or H2B-GFP (The Jackson Laboratories,
STOCK Tg(HIST1H2BB/EGFP)1Pa/J) newborn mice were prepared
using a protocol adapted from (De Palma et al, 2010). H2B-GFP
colony was maintained in hemozygous conditions and WT or H2B-
GFP transgenic pups were obtained from the same litter. After hind
limb muscles isolation, muscles were minced and digested for 1.5 h
in PBS containing 0.5 mg/ml collagenase (Sigma) and 3.5 mg/ml
dispase (Gibco). Cell suspension was filtered through a 40-µm cell
strainer and preplated in DMED + 10%FBS (Gibco), to discard the
majority of fibroblasts and contaminating cells, for 3 h. Non-adherent-
myogenic cells were collected and plated in IMDM (Gibco) + 20%
FBS + 1% Chick Embryo Extract (MP Biomedical) onto 1:100
Matrigel Reduced Factor (BD) in IMDM-coated fluorodishes. Differ-
entiation was triggered by medium switch in IMDM + 2% horse
serum, and 24 h later, a thick layer of matrigel (1:3 in IMDM) was
added. Myotubes were treated with 80 lg/ml of agrin, and the
medium was changed every 2 days (see scheme in Supplementary
Fig S1).
Latrunculin B (EMD Millipore) and nocodazole (Sigma) were
used at 10 and 75 nM, respectively, starting at day 1 or day 5 after
agrin addition (see scheme in Supplementary Fig S1A). Medium was
changed every 2 days supplemented with the drugs. C2C12 cell line
was cultured as described (De Palma et al, 2010) in DMEM + 10%
FBS (Gibco).
TA single fibers were isolated as described (Rosenblatt et al,
1995). TA muscle was explanted from 8- to 12-week-old male or
female CD1 mice and then digested in DMEM containing 0.2% type
I collagenase (Sigma) for 2 h at 37°C. Mechanical dissociation of
fibers was performed using a thin pasteur pipette and followed
under a transilluminating-fluorescent stereomicroscope.
Immunofluorescence and immunohistochemistry
The same protocol for either in vitro myofibers or isolated muscle
fibers was used. Briefly, fluorodishes or fibers were fixed in 4%
paraformaldehyde (PFA) for 10 min, permeabilized with Triton X-100
(0.5% in PBS), and aspecific sites were blocked with BSA 1% and
goat serum 10% for 30 min. Primary antibodies were added overnight
at 4°C in 0.1% saponin and 1% BSA in PBS. Fluorodishes or fibers
were washes three times and then incubated with secondary antibodies
together with DAPI for 60 min.
Peripheral nuclei quantification
Myofibers were stained for DHPR1 and DAPI and images in Z-stacks
with 0.5-lm interval were acquired with a Leica SPE confocal micro-
scope with a 63× 1.3 NA Apo objective. Nuclei extruding the myo-
fiber periphery and positively stained for DHPR were scored as
peripheral. A minimum of 150 nuclei per condition were counted in
at least three individual experiments.
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Triad quantification
Myofibers were stained for DHPR1, triadin, and DAPI and images in
Z-stacks with 0.5-lm interval were acquired with a Leica SPE confo-
cal microscope with a 63× 1.3 NA Apo objective. Myofibers having
more than 50% of triads organized, where DHPR and triadin were
transversally overlapping, were scored as positive. A minimum of
150 myofibers per condition were counted in at least three individ-
ual experiments.
Fiber thickness quantification
For fiber thickness quantification, myofibers stained for caveolin-3
to visualize plasma membrane were observed with a Leica SPE
confocal microscope with a 40× 1.3 NA Apo objective. Average of
three measurements per myofiber was performed on 100 myofibers
analyzed per each condition in at least three individual experiments.
Human biopsies
All patients or their families have agreed and signed the consent for
human sample use according to French and Japanese legislation.
Experiments were conformed to the principles set out in the WMA
Declaration of Helsinki and the NIH Belmont Report. Biopsies used for
protein homogenates to perform Western blot and immunoprecipitation
experiments were obtained from two different healthy donors (46
and 27 years old) as control. Both XLCNM patients were 1-month-
old with MTM1 c(455-49)-445-4)del and MTM1-R421insFIG, respec-
tively. ADCNM patients were 16 (E368K mutation) and 3 (R456W
mutation) years old, respectively. For ARCNM patients, we used
K575X and D151N mutated patient biopsies, previously described in
(Toussaint et al, 2011). All biopsies were frozen in liquid nitrogen
cooled isopentane (SIGMA) and kept at 80°C until use. A biopsy
from 35-year-old DM1 patient [described in (Fugier et al, 2011)]
was also used. Age-matched healthy donor biopsies were used as
control for each myopathy.
Cryosectioning and immunofluorescence microscopy
All procedures using animals were approved by the Institutional
ethics committee and followed the guidelines of the National
Research Council Guide for the care and use of laboratory animals.
For cryosectioning, the TA muscles were isolated from 8- to 12-
week-old male or female CD1 mice and frozen in isopentane
precooled with liquid nitrogen. Cryosections (10 lm thick) were
fixed in 4% PFA for 30 min. Permeabilization was performed in
cooled methanol, and aspecific sites were blocked in 5% BSA. For
human biopsies, sections were prepared as described in (Fugier
et al, 2011; Toussaint et al, 2011). Sections were then incubated
with primary antibodies overnight in PBS containing 4% BSA,
rinsed, and incubated with fluorescent secondary antibodies and
DAPI for 1 h at RT.
Microscopy
Live imaging was performed using an incubator to maintain
cultures at 37°C and 5% CO2 (Okolab) and ×20 0.3 NA PL Fluo dry
objective. Epi-fluorescence images were acquired using a Nikon Ti
microscope equipped with a CoolSNAP HQ2 camera (Roper Scien-
tific), an XY-motorized stage (Nikon), driven by Metamorph
(Molecular Devices). Multipositioning images were stitched with
Metamorph (Molecular Devices). Confocal images were acquired
using Leica SPE confocal microscope with a ×63 1.3 NA Apo
objective.
Electron microscopy was performed on cultured myofibers
10 days after agrin addition. Myofibers were fixed with 2% glutaral-
dehyde, 2% PFA in 0.1 M phosphate buffer (pH 7.4), and post-fixed
with 2% OsO4 in 0.1 M phosphate buffer for 30 min at 4°C. Myofi-
bers were then dehydrated at 4°C in acetone and stained with 1%
uranyl acetate in 70% (vol/vol) acetone, before Epon resin embed-
ding. Thin (70 nm) sections were stained with uranyl acetate and
lead citrate, observed using a Philips CM120 electron microscope
(Philips Electronics NV) and photographed with a digital SIS Morada
camera.
Transfection and electroporation
Cells were transfected with siRNA (20 nM) using RNAiMAX, cDNA
using Lipofectamine-LTX Plus reagent or both using Lipofectamine
2000 following manufacturer instructions (Invitrogen). Primary
myoblasts were transfected 6 h prior to differentiation, to allow
protein silencing or overexpression effective after differentiation
(see scheme in Supplementary Fig S1).
For in vivo muscle transfection using electroporation, we used
procedures approved by the Institutional ethics committee and
followed the guidelines of the National Research Council Guide for
the care and use of laboratory animals. siRNAs were electroporated
together with p-CITO-tdTomato (derived from pCig by substituting
nlsGFP with tdTomato cDNA) as fluorescent reporter of transfec-
tion. 20 lg of each plasmid DNA or 40 lg of siRNA were dissolved
in 40 ll of PBS and injected into the TA muscle of 8- to 12-week-old
CD1 mice (male or female) using a 27-gauge needle centered
between a pair of needle electrodes (Nepa Gene). Immediately after
the plasmid injection, six pulses of 60-ms duration at a voltage of
200 V/cm were administered with a square pulse electroporator
system CUY21SC (Nepa Gene). Muscles were retrieved 10 days after
electroporation to either cryosectioning or muscle fiber isolation.
Calcium assay
Calcium assay was performed on fully differentiated myofibers at
day 10 after agrin addition. Fluo-4 was prepared according to
manufacturer instructions (Life Technologies ref# F10471). The
myofibers were bathed in the Fluo-4 solution at 37°C for 30 min and
were then incubated at RT for another 30 min. The myofibers were
subsequently imaged using an argon laser with peak wavelength at
488 nm, on an Epi-fluorescence Nikon Ti microscope driven by
Metamorph (Molecular Devices) with image acquisition every 6 s.
Caffeine (50 mM) or KCl (50 mM) was added after 100 s. Average
of fluorescent intensity of Fluo-4 was performed on 30 myofibers
analyzed per each condition in at least three individual experiments.
Statistics
Statistical analysis was performed with Prism (version 5.0 of Graph-
Pad Software Inc.). Pairwise comparisons were made with Student’s
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t-test. In peripheral nuclei positioning analysis and in fiber thickness
analysis in myofibers, Student’s t-tests were performed between
GAPDH siRNA and experimental condition. For biochemical experi-
ments using human samples, statistical analysis was performed
using the Mann–Whitney U-test or the unpaired Student’s t-test and
multiple statistical comparisons between samples were performed
by one-way analysis of variance followed by a Bonferroni’s t-test
post hoc correction to obtain a better evaluation of the variability
between samples from the same group and samples from each
compared group and statistical significance was set at *P ≤ 0.05,
**P < 0.01, and ***P < 0.001. The prism program (version 5.0,
GraphPad software Inc.) was used. The distribution of data points is
expressed as mean  s.e.m. from three independent experiments.
Supplementary information for this article is available online:
http://embomolmed.embopress.org
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the pathological features of CNM in vitro.
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